Interferon therapy in cancer: from imaginon to interferon.
D000954:Antigens, Surface / Q000032:analysis; D000970:Antineoplastic Agents; D001943:Breast Neoplasms / Q000628:therapy; D002277:Carcinoma / Q000628:therapy; D002453:Cell Cycle / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005544:Forecasting; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007372:Interferons / Q000494:pharmacology / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000628:therapy; D007694:Killer Cells, Natural / Q000276:immunology; D007943:Leukemia, Hairy Cell / Q000628:therapy; D008223:Lymphoma / Q000628:therapy; D008264:Macrophages / Q000276:immunology; D008545:Melanoma / Q000628:therapy; D009101:Multiple Myeloma / Q000628:therapy; D009369:Neoplasms / Q000628:therapy*; D010212:Papilloma / Q000628:therapy; D012514:Sarcoma, Kaposi / Q000628:therapy
D000954:Antigens, Surface; D000970:Antineoplastic Agents; D007372:Interferons